Why the study?
Does a prediction model using 48-hour clinical data predict successful bridge to recovery in patients with fulminant myocarditis supported with percutaneous VA-ECMO?
Population
99 patients with fulminant myocarditis treated with percutaneous venoarterial extracorporeal membrane…
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
May aid early risk stratification on VA-ECMO for fulminant myocarditis; leaves open external validation before clinical adoption.
Does a prediction model using 48-hour clinical data predict successful bridge to recovery in patients with fulminant myocarditis supported with percutaneous VA-ECMO?
Sawamura et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: